Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
"Biodistribution of Monoclonal Antibodies: Scale-Up from Mouse to Human using a Physiologically Based Pharmacokinetic Model."
November 20th, 1995
According to the authors' abstract of an article published in Cancer Research, "The efficacy of a novel diagnostic or therapeutic agent depends on its selective localization in a target tissue. Biodistribution studies are expensive and difficult to carry out in humans, but such data can be obtained easily in rodents. We have developed a physiologically based pharmacokinetic model for scaling up data from mice to humans, the first such model for genetically engineered macromolecules that bind to their targets in vivo, such as mAbs. The mathematical model uses physiological parameters including organ volumes, blood flow rates, and vascular permeabilities; the compartments (organs) are...
Source: Cancer Weekly (1995-11-20)
|
|
Advertisement |
|
|
